PMID: 16507405Mar 2, 2006Paper

Tumor angiogenesis and therapy

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Y Cao

Abstract

Mutations of oncogenes and tumor suppressor genes often lead to transformation of a normal cell to become a malignant cell. However, most malignant cells cannot grow to a clinically detectable tumor mass in the absence of blood vessels. Thus, a clinically manifested large tumor has to switch on an angiogenic phenotype to support their growth. The switch of an angiogenic phenotype may represent an imbalanced expression of angiogenic factors and antiogenesis inhibitors. Overexpression of angiogenic factors and down-regulation of angiogenesis inhibitors are both necessary and sufficient to induce new blood vessels growth, and these two processes usually occur simultaneously to switch on tumor angiogenesis. The growth of blood vessels in a malignant tumor also provides structural basis for cancer metastasis. In addition to blood vessels, many tumors have the ability to induce lymphangiogenesis, which is essential for lymphatic metastasis. In this review, I will discuss current development of antiangiogenic therapy in the treatment of cancer. I present data obtained from our own research laboratory to demonstrate antiangiogenic cancer therapy.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·Y Cao
Jun 28, 2002·Cancer Cell·Judah Folkman
Jul 18, 2002·The Journal of Nutritional Biochemistry·Yihai CaoEbba Bråkenhielm

❮ Previous
Next ❯

Citations

Oct 6, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Jacek R Wilczyński, Markus Duechler
Jan 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lan G CoffmanSuzy V Torti
Jul 23, 2014·Nature Reviews. Endocrinology·Yihai Cao
Dec 23, 2011·Science Translational Medicine·Yihai CaoRobert Langer
Jan 18, 2008·Journal of Pharmaceutical Sciences·Jose L Mauriz, Javier González-Gallego
Apr 24, 2010·European Journal of Radiology·Han WangGui-Xiang Zhang
Jul 8, 2009·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·D P ToomeyK C Conlon
Apr 20, 2007·Cancer Treatment Reviews·Giuseppe LippiGian Cesare Guidi
Mar 14, 2007·British Journal of Pharmacology·J S IsenbergD D Roberts
Jun 6, 2014·Journal of Immunology Research·Glauben LandskronMarcela A Hermoso
Jan 6, 2017·Cancer Cell International·Sung Hoon Choi, Jun Yong Park
Oct 31, 2015·Virchows Archiv : an International Journal of Pathology·Toshihiro ShiozawaMasayuki Noguchi
Aug 17, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lijun JiZeng Li
May 14, 2019·Lab on a Chip·Amir K MiriYu Shrike Zhang
Apr 2, 2013·Angiogenesis·E M ProkopiouJ J Walsh
Nov 17, 2006·World Journal of Gastroenterology : WJG·Ching-Chiu LiuMarie C M Lin
Jun 4, 2016·Plastic and Reconstructive Surgery. Global Open·Nolwenn SautereauBrigitte Granel
Jun 24, 2009·Journal of Microencapsulation·Ivana d'AngeloMaría José Alonso
Oct 20, 2020·Advanced Materials Technologies·Margaux DuchampYu Shrike Zhang
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David D RobertsDavid A Wink
Nov 17, 2020·SAGE Open Medicine·Mohammad Nurul AminFarhana Sultana
Sep 2, 2020·Chemical Reviews·Ryan W BarrsYing Mei
Mar 30, 2021·OncoTargets and Therapy·Sangiliyandi GurunathanJin-Hoi Kim
Mar 3, 2017·ACS Biomaterials Science & Engineering·Yu Shrike ZhangAli Khademhosseini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.